Alexandre Becker/LinkedIn
May 15, 2026, 15:46
Alexandre Becker: Clinical Importance of Neonatal Thrombocytopenia in Newborns
Alexandre Becker, Professor of Postgraduate Studies in Clinical Hematology, Hemotherapy, and Quality Management and Control at ULBRA, shared a post on LinkedIn:
”Neonatal Thrombocytopenia
Neonatal thrombocytopenia is a common condition in neonatal intensive care units (15–40percent of infants), serving as a crucial marker of severe diseases such as sepsis, viral infection, necrotizing enterocolitis, or alloimmunization.
Its importance lies in the high risk of bleeding (including intracranial hemorrhage) and the need for rapid diagnosis to differentiate treatable causes and prevent serious sequelae or death.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 30, 2026, 05:55Benjamin YQ Tan: Exploring the Heart-Brain-Thrombosis Continuum
-
Jun 30, 2026, 05:37Maxime Dely: Blood Donation – Bridging the Global Gap in Access
-
Jun 30, 2026, 05:20Jenny Amphlett: A Decade of Excellence in Anticoagulation Care
-
Jun 30, 2026, 05:16Diana Langworthy: New Episode – Solving the DOAC vs. Warfarin Mystery in Cirrhosis
-
Jun 30, 2026, 05:06Brian Haddigan: Beyond Stent Design – The Importance of Blood Compatibility
-
Jun 30, 2026, 04:47Kaihang Wang: Portal Vein Thrombosis After Pediatric Liver Transplantation
-
Jun 30, 2026, 04:12Maia Meier: Driving Change for Women and Girls with Bleeding Disorders
-
Jun 30, 2026, 03:19Wolfgang Miesbach: Weight-Bearing Lunge Test for Ankle Assessment in Haemophilia?
-
Jun 30, 2026, 03:06Salvatore Brugaletta: Is Twelve Months of DAPT Still Too Long After ACS?